<ѻý>No-Implant Shunt Eases HF Symptoms in Early Dataѻý> Quality of life consistently improved across first-in-man studies May 20, 2022
<ѻý>TAVR Stays Its Course as 10-Year Durability Data Trickle Inѻý> Glimpse of longer-term valve degeneration in early TAVR patients May 19, 2022
<ѻý>Even With CKD, Patiromer Helped Heart Failure Patients Keep Hyperkalemia at Bayѻý> Promising findings from prespecified renal analysis of the DIAMOND trial Apr 09, 2022
<ѻý>Systemic Corticosteroids in Acute HF: Worth Another Look?ѻý> Some see a potential treatment for patients with more inflammation Apr 08, 2022
<ѻý>Patiromer Limits Impact of RAAS Inhibitor-Related Hyperkalemia in HFѻý> Patients better able to achieve target dose of mineralocorticoids and angiotensin inhibitors Apr 04, 2022
<ѻý>EHR Pop-Ups Spur Better GDMT Implementation in Heart Failureѻý> Alert-based intervention in PROMPT-HF trial said to be low-cost, scalable Apr 03, 2022
<ѻý>Low-Salt Diet Helpful for HF Symptoms, but Not Necessarily for Clinical Eventsѻý> Sodium restriction still holds its ground in SODIUM-HF trial Apr 02, 2022
<ѻý>From 'Pre-HF' to 'HFimpEF': Guidelines Redefine Heart Failure Stages, Classesѻý> Update also adds SGLT2 inhibitor as a pillar of therapy Apr 01, 2022
<ѻý>In HFpEF, Do MRA Users Get as Much Benefit From an SGLT2 Inhibitor?ѻý> EMPEROR-Preserved trial weighs in Mar 21, 2022
<ѻý>ARB-Cancer Link May Come Down to Cumulative Exposureѻý> Does a new paper resolve the conflicting safety data on the popular antihypertensives? Mar 02, 2022
<ѻý>Salt in Fizzy Tablets Linked to Heart, Death Riskѻý> Warning signals seen for fast-acting acetaminophen and other drugs Feb 24, 2022
<ѻý>A Simple Way to Tell When Asymptomatic Aortic Stenosis Isn't So Benignѻý> Could regular NT-proBNP testing be of value to patients with non-severe AS? Feb 16, 2022
<ѻý>ACIP Embraces Spikevax Amid Serious Talk of Changing mRNA Dosing Intervalѻý> Would longer time between doses do the trick to reduce myocarditis risk? Feb 04, 2022
<ѻý>Death During Sex: Not Just an Old Man Thingѻý> But sudden cardiac death remains rare even for sexually active people with heart conditions Jan 12, 2022
<ѻý>Hospitalized Acute HF Patients See Clinical Benefits With Empagliflozinѻý> EMPULSE results support early start for the SGLT2 inhibitor, but more data needed, expert says Nov 16, 2021
<ѻý>Peak VO2 Improved After Beta-Blocker Withdrawal in Some HFpEF Patientsѻý> Beta-blockers may not benefit HFpEF patients with chronotropic incompetence Nov 15, 2021
<ѻý>Delaying Surgery Hurts Patients With Silent Aortic Stenosisѻý> Early aortic valve replacement wins in AVATAR trial Nov 13, 2021
<ѻý>More Good News for Empagliflozin in Patients With Heart Failureѻý> Slower renal function decline with SGLT-2 inhibitor in EMPEROR-Preserved trial Nov 06, 2021
<ѻý>Longstanding Vascular Closure Technique Triumphs Over Collagen Plugѻý> Manta versus ProGlide after transfemoral TAVR in CHOICE-CLOSURE Nov 06, 2021
<ѻý>TAVR Operators Divided on Need for Bicuspid RCTѻý> Odds of a study coming to fruition are low Nov 05, 2021
<ѻý>Too Many TAVR Centers Are Clustered Around Well-to-Do Communitiesѻý> More centers not the answer to geographic, socioeconomic disparities in access? Oct 22, 2021
<ѻý>Study: Kids Exposed to Harmful Plastics During Heart Surgeryѻý> Are tubing and blood bags sources of trouble? Oct 09, 2021
<ѻý>Post-TAVR Pacemakers Not All Doom and Gloomѻý> A bit of reassurance from Swedish cohort study Oct 04, 2021
<ѻý>Low Risk and Bicuspid Anatomy: A Passable Combination for TAVR Thus Farѻý> Clinical outcomes not worse compared with tricuspid TAVR Sep 21, 2021
<ѻý>With HVAD Out, Innovation Key to Mechanical Circulatory Supportѻý> A debate on where LVAD innovation stands Sep 14, 2021
<ѻý>Transplant Docs Are Sticking With Invasive Biopsies After Heart Transplantsѻý> Agreement that non-invasive alternatives to EMB are not ready for routine rejection surveillance Sep 13, 2021
<ѻý>SGLT2 Inhibitor Eases Symptoms for HFpEF Patientsѻý> Trial suggests hard outcomes not the only ones helped by this class of medication Sep 13, 2021
<ѻý>Second-Gen Drug for HCM Emerges, Nipping at Mavacamten's Heelsѻý> Novel cardiac myosin inhibitor is headed for a phase III trial Sep 12, 2021
<ѻý>Heart Failure's 'Golden Moment' Not Translating into Better Healthѻý> Problems of implementation and health equity persist Sep 12, 2021
<ѻý>Feared ARNI Effect on Cognition Hasn't Come to Fruitionѻý> Neurocognitive protection by sacubitril/valsartan suggested instead by observational study Sep 12, 2021
<ѻý>Good Results When Giving Flu Shots to MI Survivors Still in the Hospitalѻý> Vaccination prior to discharge linked to heart benefit Aug 30, 2021
<ѻý>Polypills Ready for Prime Time in Large Swaths of People, Researchers Sayѻý> Question now is how to implement fixed-dose combo therapy in clinical practice Aug 29, 2021
<ѻý>His Bundle Pacing Stars in European Guidelinesѻý> Revised edition could signal coming U.S. recommendations too Aug 29, 2021
<ѻý>Ablation, CRT Boost Survival in Permanent Afib With Narrow QRSѻý> APAF-CRT trial reinforces the case for expanded CRT indication Aug 28, 2021
<ѻý>Revamped Valve Disease Guideline: Europe Sees Nearly Eye to Eye With U.S.ѻý> There is a different approach to deciding the suitability of TAVR, however Aug 28, 2021
<ѻý>A Familiar Drug Can Keep Early-Stage HCM at Bayѻý> Treatment with valsartan most beneficial when started early? Aug 27, 2021
<ѻý>Empagliflozin Improves Outcomes in HFpEF Patientsѻý> "A major win" for heart failure with preserved ejection fraction, says editorialist Aug 27, 2021
<ѻý>New Heart Failure Guidelines Released, but Are They Already Out of Date?ѻý> Results of EMPEROR-Preserved contradict guidance Aug 27, 2021
<ѻý>Milder Heart Failure Might Benefit From Implantable Monitorsѻý> Randomized trial signals benefit, albeit hampered by the pandemic Aug 27, 2021
<ѻý>Deadly Arrhythmias Less of a Risk for HF Patients on Dapagliflozinѻý> DAPA-HF analysis further explores mechanism of SGLT2 inhibitor's heart benefits Aug 27, 2021